Explore the details of the Astellas Pharma Inc. V. Msn Pharmaceuticals Inc. case under case number 1:23-cv-00689 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00689
Filing Date
Jun 23, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
MSN Laboratories Pvt. Ltd. -
Astellas Pharma Global Development, Inc. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jan 16, 2025Minute Entry for proceedings held before Judge Eleanor G. Tennyson - Telephonic Scheduling Conference held on 1/16/2025. The Court ordered the parties to submit a proposed scheduling order consistent with the dates provided at the conference by 1/22/2025. The parties are to use Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Magistrate Judge Tennyson, Forms). (Court Reporter Heather Triozzi.) Associated Cases: 1:20-cv-01589-JFB-EGT et al. (lah)PACER Document
Jan 16, 2025ORAL ORDER: IT IS HEREBY ORDERED that this case is hereinafter referred to Magistrate Judge Eleanor G. Tennyson to hear and resolve all pre-trial matters up to and including expert discovery matters, but not including summary judgment motions, Daubert motions, pre-trial motions in limine, subject to 28 U.S.C. § 636(b). Signed by Judge Joseph F. Bataillon on 1/16/25. (AEV) (Entered: 01/16/2025)PACER Document
Jan 17, 2025Motions No Longer Referred: 17 MOTION to Enforce Settlement Agreement (AEV)PACER Document
Jan 22, 2025STIPULATION TO EXTEND TIME the deadline for the parties to submit revised case schedules to January 24, 2025 - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc.. (Silver, Daniel) (Entered: 01/22/2025)PACER Document
Jan 22, 2025CORRECTING ENTRY: The Main Document of D.I. 66 MEMORANDUM AND ORDER has been replaced to reflect the removal of typographical errors. (mpb)PACER Document